AXIOM INVESTORS LLC /DE - CELLDEX THERAPEUTICS INC NEW ownership

Quarter-by-quarter ownership
AXIOM INVESTORS LLC /DE ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2015$1,824,000
-1.9%
72,309
+8.4%
0.05%
+4.0%
Q1 2015$1,859,000
+73.4%
66,699
+13.5%
0.05%
+92.3%
Q4 2014$1,072,000
+82.0%
58,760
+29.3%
0.03%
+73.3%
Q3 2014$589,00045,4500.02%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2024
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 831,648$13,040,0006.96%
DOMINI IMPACT INVESTMENTS LLC 11,451$180,0003.51%
RTW INVESTMENTS, LP 637,238$9,992,0003.30%
Parametrica Management Ltd 14,245$223,0001.47%
First Light Asset Management, LLC 208,343$3,267,0001.37%
Marcus Capital, LLC 48,450$760,0000.81%
Kazazian Asset Management, LLC 36,071$566,0000.76%
Rhenman & Partners Asset Management AB 320,000$5,018,0000.76%
Fernwood Investment Management, LLC 55,650$873,0000.75%
COLUMBIA WANGER ASSET MANAGEMENT LLC 3,610,008$56,605,0000.57%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders